{"entity":{"type":"insider","cik":"0001859509","url":"/insider/0001859509","json_url":"/insider/0001859509.json","name":"Looker Benjamin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":10,"first":"2023-01-19","last":"2026-06-18","span_basis":"filed_date"},"name_variants":[{"name":"Looker Benjamin","source":"filing","n_filings":10,"first_seen":"2023-01-19","last_seen":"2026-06-18"}],"transactions":[{"id":6157148,"accession":"0001628280-26-044269","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-044269","line_url":"/filing/0001628280-26-044269#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001859509","owner_name":"Looker Benjamin","owner_display_name":"Looker Benjamin","owner_url":"/insider/0001859509","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11824.0,"shares_display":"11,824","price_per_share":3.155,"price_display":"3.16","price_state":"stated","total_value":37304.72,"total_display":"37,304.72","total_whole":"37,305","shares_owned_after":667524.0,"shares_owned_after_display":"667,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-18","scope":"insider"},{"id":5778284,"accession":"0001628280-26-019413","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-019413","line_url":"/filing/0001628280-26-019413#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001859509","owner_name":"Looker Benjamin","owner_display_name":"Looker Benjamin","owner_url":"/insider/0001859509","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5708.0,"shares_display":"5,708","price_per_share":2.703,"price_display":"2.70","price_state":"stated","total_value":15428.724,"total_display":"15,428.72","total_whole":"15,429","shares_owned_after":679348.0,"shares_owned_after_display":"679,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-18","scope":"insider"},{"id":6023163,"accession":"0001628280-26-002925","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-002925","line_url":"/filing/0001628280-26-002925#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001859509","owner_name":"Looker Benjamin","owner_display_name":"Looker Benjamin","owner_url":"/insider/0001859509","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1689.0,"shares_display":"1,689","price_per_share":2.882,"price_display":"2.88","price_state":"stated","total_value":4867.698,"total_display":"4,867.70","total_whole":"4,868","shares_owned_after":384216.0,"shares_owned_after_display":"384,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-21","scope":"insider"},{"id":4183552,"accession":"0001628280-25-057941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-057941","line_url":"/filing/0001628280-25-057941#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001859509","owner_name":"Looker Benjamin","owner_display_name":"Looker Benjamin","owner_url":"/insider/0001859509","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6517.0,"shares_display":"6,517","price_per_share":3.667,"price_display":"3.67","price_state":"stated","total_value":23897.839,"total_display":"23,897.84","total_whole":"23,898","shares_owned_after":385905.0,"shares_owned_after_display":"385,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-18","scope":"insider"},{"id":4071905,"accession":"0001628280-25-045520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-045520","line_url":"/filing/0001628280-25-045520#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001859509","owner_name":"Looker Benjamin","owner_display_name":"Looker Benjamin","owner_url":"/insider/0001859509","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1248.0,"shares_display":"1,248","price_per_share":2.6245,"price_display":"2.62","price_state":"stated","total_value":3275.376,"total_display":"3,275.38","total_whole":"3,275","shares_owned_after":392422.0,"shares_owned_after_display":"392,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-17","filed_date":"2025-10-20","scope":"insider"},{"id":5221360,"accession":"0001859509-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001859509-25-000004","line_url":"/filing/0001859509-25-000004#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001859509","owner_name":"Looker Benjamin","owner_display_name":"Looker Benjamin","owner_url":"/insider/0001859509","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6267.0,"shares_display":"6,267","price_per_share":2.804,"price_display":"2.80","price_state":"stated","total_value":17572.668,"total_display":"17,572.67","total_whole":"17,573","shares_owned_after":393670.0,"shares_owned_after_display":"393,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-17","filed_date":"2025-09-18","scope":"insider"},{"id":5201716,"accession":"0001628280-25-035336","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-035336","line_url":"/filing/0001628280-25-035336#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001859509","owner_name":"Looker Benjamin","owner_display_name":"Looker Benjamin","owner_url":"/insider/0001859509","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1304.0,"shares_display":"1,304","price_per_share":1.127,"price_display":"1.13","price_state":"stated","total_value":1469.608,"total_display":"1,469.61","total_whole":"1,470","shares_owned_after":399937.0,"shares_owned_after_display":"399,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-17","filed_date":"2025-07-18","scope":"insider"},{"id":5112015,"accession":"0001628280-25-032219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-032219","line_url":"/filing/0001628280-25-032219#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001859509","owner_name":"Looker Benjamin","owner_display_name":"Looker Benjamin","owner_url":"/insider/0001859509","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6422.0,"shares_display":"6,422","price_per_share":1.152,"price_display":"1.15","price_state":"stated","total_value":7398.144,"total_display":"7,398.14","total_whole":"7,398","shares_owned_after":401241.0,"shares_owned_after_display":"401,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-17","filed_date":"2025-06-18","scope":"insider"},{"id":8755872,"accession":"0001628280-23-012264","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-012264","line_url":"/filing/0001628280-23-012264#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001859509","owner_name":"Looker Benjamin","owner_display_name":"Looker Benjamin","owner_url":"/insider/0001859509","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1290.0,"shares_display":"1,290","price_per_share":1.272,"price_display":"1.27","price_state":"stated","total_value":1640.88,"total_display":"1,640.88","total_whole":"1,641","shares_owned_after":83663.0,"shares_owned_after_display":"83,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-19","filed_date":"2023-04-20","scope":"insider"},{"id":8408310,"accession":"0001628280-23-001278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-001278","line_url":"/filing/0001628280-23-001278#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001859509","owner_name":"Looker Benjamin","owner_display_name":"Looker Benjamin","owner_url":"/insider/0001859509","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6347.0,"shares_display":"6,347","price_per_share":6.996,"price_display":"7.00","price_state":"stated","total_value":44403.612,"total_display":"44,403.61","total_whole":"44,404","shares_owned_after":64453.0,"shares_owned_after_display":"64,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434868","name":"Esperion Therapeutics, Inc.","url":"/issuer/0001434868","role":"Officer (Chief Legal Officer)","n_filings":10,"first_seen":"2023-01-19","last_seen":"2026-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001859509","retrieved_at":"2026-08-25T05:30:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}